ARCHIVES

SAIC Begins Transition Of Frederick Operations From Incumbent PRI

This article is from The Cancer Letter archive.

Vol. 21 No. 11 | March 17, 1995

Download PDF Visit The Full Archive

Related Articles

ODAC Rejects Amsacrine NDA, Renews Idarubicin

September 14, 1990

$1.5 Million In Direct Costs Is Proposed Core Grant Requirement

July 12, 1991

GA Draft Report Lukewarm On Cancer Survival Improvement; NCI Says It Is “Opinion, Not Fact”

April 3, 1987

ASCO Endorses Guideline for Molecular Testing

October 17, 2014

Congress Signals Willingness to Break With Administration on NIH Funding.

March 24, 2006

Capitol Hill: Senate bill would allow sale of therapies for catastrophic illness after phase I trials.

December 2, 2005